Trials / Completed
CompletedNCT03703557
Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer
Feasibility Study on the Possibility of Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Institut Curie · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To ascertain the possibilities to isolate the breast cancer olfactive signature.
Detailed description
Patient recruitment during the first surgery consultation in Curie Institute. Odor sampling (non-invasive) with an odor-sensing polymer (Sorbstar® polymer developed especially for the trace level analysis), on: * The hands, before and after surgical excision of the tumor (friction of the hands) * The diseased breast, before and after surgical excision of the tumor (via a compress positioned on the breast for 1 night) * The tumor, during the surgical procedure (odor collection over a tumor sample). Each patient will be her own witness, before and after surgical excision, in an attempt to isolate the chemical signature tracks of breast cancer. The samples after surgery will be made after healing and before implementation of a treatment (chemotherapy and / or radiotherapy).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Sorbstar® | Thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry. |
| DIAGNOSTIC_TEST | Odour sampling | Analyzed by the dogs of Curie Institute at the training centers |
Timeline
- Start date
- 2018-07-25
- Primary completion
- 2019-09-20
- Completion
- 2020-09-20
- First posted
- 2018-10-12
- Last updated
- 2020-12-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03703557. Inclusion in this directory is not an endorsement.